300 episodes

The most important stories about money, business and power. Hosted by Kate Linebaugh and Ryan Knutson, with Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal.

Get show merch here: https://wsjshop.com/collections/clothing

The Journal‪.‬ The Wall Street Journal

    • News
    • 4.3 • 4.7K Ratings

The most important stories about money, business and power. Hosted by Kate Linebaugh and Ryan Knutson, with Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal.

Get show merch here: https://wsjshop.com/collections/clothing

    Fentanyl Is Bad. ‘Tranq’ Might Be Worse.

    Fentanyl Is Bad. ‘Tranq’ Might Be Worse.

    The animal tranquilizer xylazine, also known as “tranq,” is finding its way into opioid supplies and wreaking havoc all over the country. It’s rotting people’s flesh, leading to amputations and complicating drug treatment. WSJ’s Julie Wernau takes us to Robeson County, N.C., the new “ground zero” for xylazine addiction.



    Further Reading:

    - Flesh-Rotting ‘Tranq’ Undermines Fight Against Fentanyl 

    - Recovering From Drug Addiction Was Hard. Tranq Made It Worse. 

    - Nurses Make House Calls to Treat ‘Tranq’ Wounds for Users at Society’s Edge 



    Further Listening:

    - Why Some Opioid Victims Are Challenging Purdue’s Settlement 

    - How a Drug Maker Plans to Cut Off Money for Opioid Victims  



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 19 min
    ‘It Felt Surreal’: A Cancer Diagnosis at 26

    ‘It Felt Surreal’: A Cancer Diagnosis at 26

    Meilin Keen was diagnosed with stomach cancer at 26. She’s part of a growing demographic of people who are getting cancer diagnoses before the age of 50. And doctors don’t know why. WSJ’s Brianna Abbott explains what we know so far.



    Further Reading:

    -Cancer Is Striking More Young People, and Doctors Are Alarmed and Baffled. 

    -Many Cancers Are on the Rise in the U.S., Even as Overall Deaths Fall. 

    -Uterine Cancer Was Easy to Treat. Now It’s Killing More Women Than Ever. 

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 18 min
    Alexei Navalny, Putin’s Loudest Critic, Dies in a Russian Prison

    Alexei Navalny, Putin’s Loudest Critic, Dies in a Russian Prison

    For years, anti-corruption activist Alexei Navalny has been an outspoken critic and political foe of Russian President Vladimir Putin. Today, Russian prison authorities reported Navalny died at the age of 47. WSJ’s Ann Simmons delves into Navalny’s life, death and what this moment means for Russia.



    Further Reading:

    - Alexei Navalny Spent His Final Years Hounded—but Undeterred—by the Kremlin 

    - Alexei Navalny, the Kremlin’s Most Ardent Critic, Dies in Prison 



    Further Listening:

    - Russia's Media Crackdown: 'The Future is Pretty Dark' 

    - The Plane Crash That Killed Yevgeny Prigozhin 

    - Inside Russia’s Spy Unit Targeting Americans 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 21 min
    The Deal to Hide Bad Actors in the Funeral Industry

    The Deal to Hide Bad Actors in the Funeral Industry

    Unethical funeral homes have exploited grieving customers for decades. What consumers may not know is that many of the industry’s bad actors have been hidden from the public thanks to a sweetheart deal struck between the Federal Trade Commission and the funeral industry more than 25 years ago. WSJ’s Dominique Mosbergen unpacks her multi-year investigation.



    Further Reading:

    - How the Funeral Industry Got the FTC to Hide Bad Actors 



    Further Listening:

    - FTC Chair Lina Khan on Microsoft Merger, ChatGPT and Her Court Losses 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 21 min
    Sam Altman’s $7 Trillion ‘Moonshot’

    Sam Altman’s $7 Trillion ‘Moonshot’

    OpenAI and its CEO Sam Altman kicked off an AI revolution with the viral ChatGPT. Now, Altman has set his sights on another ambitious goal: Raise up to $7 trillion to overhaul the world’s semiconductor chip industry. WSJ’s Keach Hagey explains what the plan entails, and why skeptics think it will be an uphill battle.



    Further Listening:

    - Artificial: The OpenAI Story 



    Further Reading:

    - Sam Altman Seeks Trillions of Dollars to Reshape Business of Chips and AI 

    - Raising Trillions of Dollars Might Be the Easy Part of Altman’s Chip Plan 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 22 min
    The Spectacular Fall of 23andMe

    The Spectacular Fall of 23andMe

    Five years ago, 23andMe was one of the buzziest startups in the world. Now, 23andMe’s stock is worth less than $1. WSJ’s Rolfe Winkler unpacks the startup’s meteoric rise and fall.



    Further Reading and Watching:

    - 23andMe’s Fall From $6 Billion to Nearly $0 

    - How 23AndMe Went From a $6 Billion Valuation to a Penny Stock 

    - 23andMe Mulls Possible Split, Shares Fall After Disappointing Results 



    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 17 min

Customer Reviews

4.3 out of 5
4.7K Ratings

4.7K Ratings

newsjunqui ,

Charlie Munger

Terrific podcast about a great man I knew so little about.

Rick Leary ,

Very Informative

I listen to this podcast several times a week. I find the podcast very informative and presented in an understandable way. I only skip a few podcasts. It is great for someone who wants to keep informed but is not looking to get into the details. The podcasts give you enough information that you can decide if you want to learn more.

LondonBizOwner ,

WSJ proves journalism is dead

These journalists have no idea how businesses actually work. They are a bunch of anti-capitalists who still rely on their parents to pay for their way in life. Why doesn’t WSJ at least have them interview people who run businesses? Then at least we’d be hearing from someone other than a liberal arts grad who has never so much as managed a team, let alone raised funds or built a product. How sad to be a journalist in 2024. Your opinions don’t matter and your takes are invalid because people want to hear takes from people who’ve actually accomplished something. If you think you’re a “writer”, just write creative fiction or biographies. WSJ has no future.

Top Podcasts In News

The New York Times
NPR
Crooked Media
The Daily Wire
Tucker Carlson
Becker's Healthcare

You Might Also Like

The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
The New York Times

More by The Wall Street Journal

The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
The Wall Street Journal
Paul Gigot, The Wall Street Journal